Affinity-matured HLA class II dimers for robust staining of antigen-specific CD4+ T cells

Kenji Sugata1, Yukiko Matsunaga1, Yuki Yamashita1

  • 1Tumor Immunotherapy Program, Campbell Family Institute for Breast Cancer Research, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.

Nature Biotechnology
|March 2, 2021
PubMed